Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
GSK Supply Status
At this time, COVID-19 is not having an impact on GSK supply in the UK.
Please note: this page is updated weekly. If a product is not listed below, GSK are not experiencing supply constraints. Please contact your wholesaler
Product name |
PIP Code |
Status |
Estimated recovery date |
|---|---|---|---|
| BECONASE ANS 50MCG 1X200D_GB | 383307 | OUT OF STOCK | LATE NOVEMBER 2024 |
| EUMOVATE CRM 0.05% 100G UK-GSK | 483503 | OUT OF STOCK | LATE NOVEMBER 2024 |
| IMIGRAN N.S. 10MGX2 CP GB | 2946960 | OUT OF STOCK | EARLY JANUARY 2025 |
| IMIGRAN N.S. 20X6 CP UK | 2330728 | OUT OF STOCK | EARLY DECEMBER 2024 |
| IMIGRAN TABLET 50MG 1X6 | 2095685 | OUT OF STOCK | LATE NOVEMBER 2024 |
| IMIGRAN TABLET 100MG 1X6 | 109546 | OUT OF STOCK | LATE NOVEMBER 2024 |
| IMIGRAN RADIS TABL 50MG 1X6 | 3054855 | OUT OF STOCK | LATE NOVEMBER 2024 |
| SEREVENT EVH 25MCG-INH 134A 1X120D GB | 3164142 | OUT OF STOCK | LATE NOVEMBER 2024 |
| VENTOLIN RESP SOLN 20ML UK-AH | 3445525 | OUT OF STOCK | LATE NOVEMBER 2024 |
Product name |
PIP Code |
Status |
Estimated recovery date |
|---|
If you have any queries about the availability of a product, please contact your wholesaler.
3rd Party Distribution
From 1st Sept 2023, GSK and Recordati have agreed a deal whereby RECORDATI PHARMACEUTICALS LIMITED will take over the Distribution and Commercial activities for the following products.
Product name |
PIP Code |
|---|---|
| AVODART Capsules 0.5mg x 30 | 2921070 |
| COMBODART Capsules 0.5mg/0.4mg x 30 | 3542560 |
Orders can be placed at this email address:
Further information
If you require further information, please contact our UK Customer Contact Centre (customercontactuk@gsk.com).
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
